Families and individuals navigating the challenges of autism have found a powerful solution through the QPAN® (QEEG-Guided Personalized AI-Based Neuromodulation and Rehabilitation) Model., a groundbreaking neuro-rehabilitation system offering personalized, AI-driven brain function therapy. Developed by Cosmos Healthcare and pioneered by Dr. Alptekin Aydin, QPAN® combines cutting-edge technology with a holistic therapeutic approach, delivering targeted interventions that improve cognitive function, emotional well-being, and overall quality of life for those on the autism spectrum. With over 5,000 users already benefiting from its advanced protocols and a success rate of 70-85%, QPAN® is quickly becoming a beacon of hope for families and individuals living with autism and other neurological conditions.
At the core of the QPAN® Model is its unique approach to mapping and improving brain function through QEEG (quantitative electroencephalography), which provides a detailed “neuromap®” of brain activity. This neuromap® allows clinicians to identify areas of abnormal brainwave patterns that may be linked to cognitive, emotional, and sensory challenges faced by individuals with autism.
Central to the system is Neuromap®, a proprietary artificial intelligent platform continuously learning by itself, developed by Dr. Aydin and his team at Cosmos. Neuromap® uses qEEG technology to create a detailed map of brain activity. By measuring electrical signals within the brain, qEEG pinpoints areas of dysfunction, helping to identify cognitive, emotional, and behavioral challenges. This data is then processed by Neuromap’s® advanced AI algorithms, which analyze the patterns and generate a personalized, comprehensive map of the brain’s strengths and weaknesses.
This precise mapping allows the QPAN® system to develop highly tailored treatment plans for each patient. QPAN® integrates a range of therapies, from Transcranial Direct Current Stimulation (tDCS) to speech, occupational, and physical therapy. Using low-intensity electrical currents, tDCS stimulates specific brain areas, improving cognitive function and enhancing mood. Meanwhile, therapy and educational programs are adapted to the individual’s brain profile, ensuring that learning strategies and physical activities are aligned with their unique neurological needs.
“QPAN® is more than just a therapeutic model,” said Dr. Aydin, the creator of the QPAN® system. “It’s a comprehensive neuro-rehabilitation solution that addresses not only the brain’s physiological needs but also the emotional and cognitive well-being of the patient. By leveraging Neuromap’s® AI-driven brain mapping, we can offer a level of personalization that was previously unattainable.”
Neuromap®’s AI plays a crucial role in this process, constantly analyzing brainwave patterns to track real-time changes and adapting treatment as needed. The AI’s capacity to continuously update and refine treatment plans ensures each patient receives a truly customized approach, providing more effective and efficient results over time.
For individuals on the autism spectrum, this personalized care is transformative. The QPAN® model combines therapies across multiple domains, including educational support, sports, and nutrition programs, each designed to target and enhance specific brain regions. QPAN® centralizes the focus on holistic care, ensuring a unified system of care supports the individual's physical, emotional, and intellectual development.
Families of those battling autism have noted the positive changes in their loved ones, as the QPAN® model not only improves cognitive function but also enhances social communication, emotional regulation, and overall quality of life. By integrating qEEG-guided neuromodulation with therapy and education, QPAN® offers a complete package of care that adapts to the patient’s needs throughout their journey.
Since its introduction in Germany in 2018, the QPAN® Model has transformed the lives of over 5,000 individuals, with an astounding success rate of 70-85%. Cosmos Healthcare International is now expanding the system globally, bringing this life-changing therapy to more clinics and families around the world.
About Cosmos Healthcare International:
Cosmos Healthcare International is a leader in neurorehabilitation and mental health care innovation. With a commitment to personalized therapy, the company’s mission is to revolutionize treatment options for individuals with neurological and psychological conditions. The QPAN® Model is part of their larger vision to integrate advanced technology with holistic therapeutic approaches for superior patient outcomes.
This is a PR article which has been published as received without any editorial enhancement, or modification.. The Telegraph Online does not endorse or guarantee the accuracy, reliability, or completeness of any information presented in the article. The organization is not responsible for any errors or omissions in the content or for any losses, damages, or injuries arising from the use of the information provided in the article.
